(Q51041613)

27 March 2018

title

Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome. (English)

1 reference

27 March 2018

1 reference

6

Kimberlee Gauvreau

1 reference

27 March 2018

Ami B Bhatt

1

1 reference

27 March 2018

J Stewart Buck

2

1 reference

27 March 2018

Jonah P Zuflacht

3

1 reference

27 March 2018

Jessica Milian

4

1 reference

27 March 2018

Samoneh Kadivar

5

1 reference

27 March 2018

Michael N Singh

7

1 reference

27 March 2018

Mark A Creager

8

1 reference

27 March 2018

publication date

20 March 2015

1 reference

27 March 2018

published in

Vascular Medicine

1 reference

27 March 2018

volume

20

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

317-325

1 reference

27 March 2018

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Augmentation index assessed by applanation tonometry is elevated in Marfan Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effects of age on ventricular-vascular coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Primary impairment of left ventricular function in Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Tissue Doppler imaging identifies myocardial dysfunction in adults with marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Atenolol versus losartan in children and young adults with Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Expert consensus document on arterial stiffness: methodological issues and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

A comparison of atenolol and nebivolol in isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effect of different antihypertensive drug classes on central aortic pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

The effect of an Angiotensin receptor blocker on arterial stiffness in type 2 diabetes mellitus patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Heart rate dependency of pulse pressure amplification and arterial stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

Heterogeneous aortic response to acute β-adrenergic blockade in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X15569868

21 January 2018

Identifiers

DOI

10.1177/1358863X15569868

1 reference

27 March 2018

1 reference

27 March 2018